RxDoctor Payments Data

Casey Phan, MD

Anatomic Pathology & Clinical Pathology · Honolulu, HINPI 1720421118

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AstraZeneca accounts for 84.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for anatomic pathology & clinical pathology clinicians in HI, where the typical reported total is $240.

$154in general payments, 2019–2025

Across 3 payments — averaging $51.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$130
  • Amgen$24

What the payments were for

  • Food & beverage$154100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$130
Amgen2$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$154 in reported general payments places this provider in the 40th percentile of 42 anatomic pathology & clinical pathology providers in Hawaii.

See all anatomic pathology & clinical pathology providers in Hawaii

Medicare billing

Part B allowed, 2024
$415,286
Medicare patients
1,866
Services billed
5,348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →